| NCT03374358 |
Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir |
https://ClinicalTrials.gov/show/NCT03374358 |
Completed |
Helsinki University Central Hospital |
2019-11-02 |
| NCT03367130 |
Improving Clinic Attendance for Medication Collection Among HIV Positive Individuals in Nepal |
https://ClinicalTrials.gov/show/NCT03367130 |
Completed |
Tokyo University |
2018-06-30 |
| NCT03333083 |
Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen |
https://ClinicalTrials.gov/show/NCT03333083 |
Recruiting |
Hospital Clinic of Barcelona |
2020-03-30 |
| NCT03311945 |
Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM |
https://ClinicalTrials.gov/show/NCT03311945 |
Recruiting |
Hospital Clinic of Barcelona |
2020-03-30 |
| NCT03292913 |
Positive Health Check Evaluation Trial |
https://ClinicalTrials.gov/show/NCT03292913 |
Active, not recruiting |
RTI International |
2020-10-31 |
| NCT03218839 |
Evaluation of the PrePex Device for Rapid Scale-up of VMMC, Phase 3 Field Implementation Trial With HIV + Adult Males |
https://ClinicalTrials.gov/show/NCT03218839 |
Completed |
University of Washington |
2016-02-29 |
| NCT03213028 |
Family Planning Service Delivery Integration For HIV Positive And At-Risk Women In Botswana: A Hybrid Type 2 Clinical Intervention And Implementation Strategy |
https://ClinicalTrials.gov/show/NCT03213028 |
Completed |
University of Pennsylvania |
2018-08-10 |
| NCT03134924 |
Vaginal Practices in Human Immunodeficiency Virus (HIV) Positive Women in Zambia, a Bio-Behavioral Intervention “WASH-2” |
https://ClinicalTrials.gov/show/NCT03134924 |
Completed |
University of Miami |
2014-02-05 |
| NCT03124914 |
Relationship Between Neuromuscular Fatigue, Perceived Tiredness and Level Of Physical Activity of Patients Living With HIV |
https://ClinicalTrials.gov/show/NCT03124914 |
Completed |
Centre Hospitalier Universitaire de Nice |
2018-04-19 |
| NCT03073421 |
Positive Pregnancy Program |
https://ClinicalTrials.gov/show/NCT03073421 |
Completed |
St. Michael’s Hospital, Toronto |
2016-09-01 |
| NCT03004170 |
Telephone Counseling to Enhance the Quality and Safety of Romantic and Sexual Relationships in People Living and Aging With HIV |
https://ClinicalTrials.gov/show/NCT03004170 |
Active, not recruiting |
Oregon Health and Science University |
2020-12-31 |
| NCT02994329 |
Community-based Distribution of Oral HIV Self-testing Kits |
https://ClinicalTrials.gov/show/NCT02994329 |
Completed |
Zambart |
2017-09-30 |
| NCT02938377 |
Alcohol Research Consortium in HIV-Intervention Research Arm |
https://ClinicalTrials.gov/show/NCT02938377 |
Recruiting |
University of Alabama at Birmingham |
2021-08-31 |
| NCT02935296 |
Integrated Treatment and Prevention for People Who Inject Drugs |
https://ClinicalTrials.gov/show/NCT02935296 |
Completed |
HIV Prevention Trials Network |
2017-06-16 |
| NCT02921516 |
Growing Up: Intervening With HIV-Positive Adolescents in Resource-Poor Settings |
https://ClinicalTrials.gov/show/NCT02921516 |
Completed |
Florida International University |
2018-05-31 |
| NCT02833441 |
The Peer Support Intervention - Supporting HIV Positive Adolescents in Zimbabwe to Improve HIV Care Continuum Outcomes |
https://ClinicalTrials.gov/show/NCT02833441 |
Completed |
University of Zimbabwe |
2018-03-31 |
| NCT02689895 |
Etiology of Treatment Failure in HIV Positive Children and Adolescents on Boosted Protease Inhibitor-based Regimens |
https://ClinicalTrials.gov/show/NCT02689895 |
Completed |
University of Zimbabwe |
2017-01-31 |
| NCT02677675 |
Effectiveness of Mobile Phone Technology on Adherence and Treatment Outcomes Among HIV Positive Patients on ART |
https://ClinicalTrials.gov/show/NCT02677675 |
Completed |
Universiti Putra Malaysia |
2014-12-31 |
| NCT02676167 |
Public Health Targeting of PrEP at HIV Positives’ Bridging Networks |
https://ClinicalTrials.gov/show/NCT02676167 |
Completed |
University of Chicago |
2019-05-31 |
| NCT02590354 |
Analytical Treatment Interruption in HIV Positive Patients |
https://ClinicalTrials.gov/show/NCT02590354 |
Completed |
Institute of Tropical Medicine, Belgium |
2018-06-22 |
| NCT03397420 |
Family-centered HIV Care, Viral Suppression and Retention in HIV-positive Children, Swaziland |
https://ClinicalTrials.gov/show/NCT03397420 |
Completed |
Elizabeth Glaser Pediatric AIDS Foundation |
2018-10-30 |
| NCT02546271 |
A Small-group Intervention to Reduce HIV Sexual Transmission Risk Behavior Among HIV-positive Men Who Have Sex With Men |
https://ClinicalTrials.gov/show/NCT02546271 |
Completed |
Ryerson University |
2013-11-30 |
| NCT02535429 |
Massage Therapy for HIV-positive People : Effects on Anxiety, Depression, Hyperventilation and Quality of Life |
https://ClinicalTrials.gov/show/NCT02535429 |
Completed |
Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
2015-12-31 |
| NCT02371265 |
Early ART Initiation Among HIV-positive Pregnant Women in Central Mozambique |
https://ClinicalTrials.gov/show/NCT02371265 |
Completed |
University of Washington |
2015-08-31 |
| NCT02338024 |
Enhancing Linkage to HIV Care for Newly Detected HIV-positive Persons in Ukraine |
https://ClinicalTrials.gov/show/NCT02338024 |
Completed |
Ukrainian Institute on Public Health Policy |
2017-10-03 |
| NCT02190643 |
Improving Nicotine Patch Adherence Among Latino HIV-Positive Smokers |
https://ClinicalTrials.gov/show/NCT02190643 |
Completed |
RAND |
2015-11-30 |
| NCT02153788 |
Efficacy and Safety of Temazepam in HIV Seropositive Patients With Insomnia |
https://ClinicalTrials.gov/show/NCT02153788 |
Completed |
Duke University |
2010-09-30 |
| NCT01296113 |
Chemotherapy for Lung Cancer in HIV-positive Patients |
https://ClinicalTrials.gov/show/NCT01296113 |
Completed |
Intergroupe Francophone de Cancerologie Thoracique |
2016-01-31 |
| NCT01295034 |
Vitamin D Supplements for HIV-positive Patients on cART |
https://ClinicalTrials.gov/show/NCT01295034 |
Completed |
Icahn School of Medicine at Mount Sinai |
2015-06-30 |
| NCT02029430 |
A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi’s Sarcoma |
https://ClinicalTrials.gov/show/NCT02029430 |
Completed |
CytRx |
2015-12-31 |
| NCT02012556 |
Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients |
https://ClinicalTrials.gov/show/NCT02012556 |
Completed |
Theratechnologies |
2008-07-31 |
| NCT02011958 |
Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients. |
https://ClinicalTrials.gov/show/NCT02011958 |
Completed |
Drugs for Neglected Diseases |
2016-08-31 |
| NCT01957917 |
Comparing Food and Cash Assistance for HIV-Positive Men and Women on Antiretroviral Therapy in Tanzania |
https://ClinicalTrials.gov/show/NCT01957917 |
Completed |
University of California, Berkeley |
2016-10-31 |
| NCT01941121 |
CCTG 593: Testing and Linkage to Care |
https://ClinicalTrials.gov/show/NCT01941121 |
Active, not recruiting |
University of California, San Diego |
2018-01-22 |
| NCT01910493 |
Evaluation of the Impact of Mobile Phone Messages on ART and PMTCT Adherence in Mozambique |
https://ClinicalTrials.gov/show/NCT01910493 |
Completed |
Absolute Return for Kids |
2013-05-31 |
| NCT01898754 |
Oligonucleotide Ligation Assay (OLA) Resistance Study |
https://ClinicalTrials.gov/show/NCT01898754 |
Completed |
University of Washington |
2016-12-31 |
| NCT01881971 |
Statins for Pulmonary and Cardiac Complications of Chronic HIV - Coordinating Center |
https://ClinicalTrials.gov/show/NCT01881971 |
Completed |
University of Pittsburgh |
2015-11-30 |
| NCT01818258 |
IMPAACT P1092: Steady State PK in Malnourished HIV Infected Children |
https://ClinicalTrials.gov/show/NCT01818258 |
Completed |
International Maternal Pediatric Adolescent AIDS Clinical Trials Group |
2017-04-11 |
| NCT01816828 |
Intervention Research to Reduce HIV Sexual Transmission Among HIV Positive Men Who Have Sex With Men |
https://ClinicalTrials.gov/show/NCT01816828 |
Completed |
Ryerson University |
2018-08-31 |
| NCT01751620 |
Project ACCEPT: Engaging Newly Diagnosed HIV+ Youth in Care |
https://ClinicalTrials.gov/show/NCT01751620 |
Completed |
University of North Carolina, Chapel Hill |
2015-06-30 |
| NCT01733927 |
An Evaluation of a Rapid Test for HIV |
https://ClinicalTrials.gov/show/NCT01733927 |
Completed |
Pontificia Universidad Catolica de Chile |
2010-11-30 |
| NCT01723956 |
Validation of Implementation of Cervical Dysplasia Treatment Modalities in HIV-Seropositive Women |
https://ClinicalTrials.gov/show/NCT01723956 |
Completed |
University of Witwatersrand, South Africa |
2014-08-31 |
| NCT01721798 |
Comparison of Two IUDs Among Cape Town HIV-positive Women |
https://ClinicalTrials.gov/show/NCT01721798 |
Completed |
FHI 360 |
2018-07-13 |
| NCT01689545 |
Prevention for Positives: An RCT Among Vietnamese HIV-positive IDU |
https://ClinicalTrials.gov/show/NCT01689545 |
Completed |
Johns Hopkins Bloomberg School of Public Health |
2013-04-30 |
| NCT01537367 |
Intervention to Retain HIV-positive Patients in Medical Care |
https://ClinicalTrials.gov/show/NCT01537367 |
Completed |
Centers for Disease Control and Prevention |
2012-02-29 |
| NCT01499706 |
Telephone-delivered Behavioral Interventions to Reduce Risky Sexual Behavior in HIV-positive Late Middle-age and Older Adults |
https://ClinicalTrials.gov/show/NCT01499706 |
Completed |
Ohio University College of Osteopathic Medicine |
2010-10-31 |
| NCT01354210 |
Text Messaging Intervention to Improve ART Adherence Among HIV-positive Youth |
https://ClinicalTrials.gov/show/NCT01354210 |
Completed |
Ann & Robert H Lurie Children’s Hospital of Chicago |
2013-03-31 |
| NCT01350544 |
Treatment Advocacy Intervention for HIV-Positive African Americans |
https://ClinicalTrials.gov/show/NCT01350544 |
Completed |
Boston Children’s Hospital |
2015-07-31 |
| NCT04124536 |
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women |
https://ClinicalTrials.gov/show/NCT04124536 |
Recruiting |
University of North Carolina, Chapel Hill |
2021-01-31 |
| NCT03858478 |
Initiation of First-line Antiretroviral Treatment With TENOFOVIR ALAFENAMIDE - EMTRICITABINE - BICTEGRAVIR at the First Clinical Contact in France: Trial IMEA 055 - FAST |
https://ClinicalTrials.gov/show/NCT03858478 |
Recruiting |
Institut de Médecine et d’Epidémiologie Appliquée - Fondation Internationale Léon M’Ba |
2021-03-31 |
| NCT03531749 |
Antioxidant in Patients HIV+ Supplemented With Microencapsulated of Red Pomegranate |
https://ClinicalTrials.gov/show/NCT03531749 |
Completed |
Universidad Autónoma del Estado de Hidalgo |
2017-05-31 |
| NCT03517358 |
Virological Suppression in HIV Positive Patients Involved in a Novel Standardized Adherence Protocol |
https://ClinicalTrials.gov/show/NCT03517358 |
Recruiting |
University of California, Davis |
2019-12-31 |
| NCT03483857 |
Peer Navigation to Improve Engagement in Care for HIV-Positive Men Who Have Sex With Men in Ehlanzeni, South Africa |
https://ClinicalTrials.gov/show/NCT03483857 |
Completed |
University of California, San Francisco |
2018-06-29 |
| NCT03432819 |
A Pilot Intervention to Improve Coping With Discrimination and Adherence Among HIV-Positive Latino MSM |
https://ClinicalTrials.gov/show/NCT03432819 |
Active, not recruiting |
RAND |
2020-08-31 |
| NCT01246401 |
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations |
https://ClinicalTrials.gov/show/NCT01246401 |
Completed |
Yale University |
2016-03-31 |
| NCT01211288 |
Longitudinal Study of Dental Implant Therapy in HIV Positive Patients |
https://ClinicalTrials.gov/show/NCT01211288 |
Completed |
University of Alabama at Birmingham |
2019-04-01 |
| NCT01174914 |
Effectiveness Study Low-Dose Naltrexone Versus ARV’s for HIV+ |
https://ClinicalTrials.gov/show/NCT01174914 |
Completed |
The Ojai Foundation |
2010-03-31 |
| NCT01140880 |
Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men |
https://ClinicalTrials.gov/show/NCT01140880 |
Completed |
Friends Research Institute, Inc. |
2013-03-31 |
| NCT01122186 |
Intervention Targeting Medication Adherence and Methamphetamine Use in HIV Positive Men (ACE) |
https://ClinicalTrials.gov/show/NCT01122186 |
Completed |
Hunter College of City University of New York |
2012-01-31 |
| NCT00990678 |
Study of Vitamin D Supplementation to Male HIV Sero-positive Patients |
https://ClinicalTrials.gov/show/NCT00990678 |
Completed |
Hvidovre University Hospital |
2010-02-28 |
| NCT00959361 |
Evaluation of Effectiveness of Pharmaceutical Care on the Adherence of HIV-Positive Patients to Antiretroviral Therapy |
https://ClinicalTrials.gov/show/NCT00959361 |
Completed |
Hospital de Clinicas de Porto Alegre |
2009-05-31 |
| NCT00941889 |
The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata |
https://ClinicalTrials.gov/show/NCT00941889 |
Completed |
Washington University School of Medicine |
2011-07-31 |
| NCT01957748 |
CCTG 594: Engagement and Retention in Care for HIV+ |
https://ClinicalTrials.gov/show/NCT01957748 |
Active, not recruiting |
University of California, San Diego |
2017-12-15 |
| NCT01751594 |
Testing a Secondary Prevention Intervention for HIV-Positive Black Young Men Who Have Sex With Men |
https://ClinicalTrials.gov/show/NCT01751594 |
Completed |
University of North Carolina, Chapel Hill |
2014-06-30 |
| NCT00741637 |
Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults |
https://ClinicalTrials.gov/show/NCT00741637 |
Completed |
International Vaccine Institute |
2011-04-30 |
| NCT00721305 |
Lovastatin: Immunomodulatory Value Evaluation |
https://ClinicalTrials.gov/show/NCT00721305 |
Completed |
Universidad de Antioquia |
2011-07-31 |
| NCT00686205 |
Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay |
https://ClinicalTrials.gov/show/NCT00686205 |
Completed |
Abbott Diagnostics Division |
2008-08-31 |
| NCT00659971 |
Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis |
https://ClinicalTrials.gov/show/NCT00659971 |
Completed |
Pacgen Biopharmaceuticals Corporation |
2008-06-30 |
| NCT00551720 |
Motivation and Patch Treatment for HIV-positive Smokers |
https://ClinicalTrials.gov/show/NCT00551720 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00444977 |
Enhancing Oral Health Care Use by HIV Positive Individuals |
https://ClinicalTrials.gov/show/NCT00444977 |
Completed |
Columbia University |
2009-12-31 |
| NCT00429845 |
Effect of Nutritional Intervention on the Lipid Profile of HIV-Positive Patients Who Start HAART: a Randomized Trial |
https://ClinicalTrials.gov/show/NCT00429845 |
Completed |
Hospital de Clinicas de Porto Alegre |
NA |
| NCT00381212 |
A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent. |
https://ClinicalTrials.gov/show/NCT00381212 |
Completed |
McGill University Health Centre/Research Institute of the McGill University Health Centre |
2008-02-29 |
| NCT00367458 |
Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Therapy |
https://ClinicalTrials.gov/show/NCT00367458 |
Completed |
National Institutes of Health Clinical Center (CC) |
2008-06-19 |
| NCT00343317 |
Prophylactic Intrapartum Antibiotics and Immunological Markers for Postpartum Morbidity in HIV Positive Women |
https://ClinicalTrials.gov/show/NCT00343317 |
Completed |
University of KwaZulu |
NA |
| NCT00270530 |
Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia |
https://ClinicalTrials.gov/show/NCT00270530 |
Completed |
Center for International Health and Development |
NA |
| NCT00213083 |
Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission |
https://ClinicalTrials.gov/show/NCT00213083 |
Completed |
Population Council |
2007-04-30 |
| NCT00213005 |
Safety and Acceptability of Carraguard® in HIV Positive Women and Men |
https://ClinicalTrials.gov/show/NCT00213005 |
Completed |
Population Council |
NA |
| NCT00197678 |
Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive Women |
https://ClinicalTrials.gov/show/NCT00197678 |
Completed |
Harvard School of Public Health |
2005-07-31 |
| NCT00130819 |
Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants |
https://ClinicalTrials.gov/show/NCT00130819 |
Completed |
Johns Hopkins University |
2009-04-30 |
| NCT00116636 |
Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients |
https://ClinicalTrials.gov/show/NCT00116636 |
Completed |
Therapeutic Concepts |
NA |
| NCT00086710 |
Study of Enfuvirtide in HIV-Positive Subjects |
https://ClinicalTrials.gov/show/NCT00086710 |
Completed |
Trimeris |
NA |
| NCT00035893 |
The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART |
https://ClinicalTrials.gov/show/NCT00035893 |
Completed |
AIM ImmunoTech Inc. |
2006-08-31 |
| NCT00447798 |
Project Hope: Hospital Visit is an Opportunity for Prevention and Engagement With HIV-positive Crack Users |
https://ClinicalTrials.gov/show/NCT00447798 |
Completed |
Columbia University |
2011-03-31 |
| NCT00009555 |
Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat |
https://ClinicalTrials.gov/show/NCT00009555 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00002321 |
A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis |
https://ClinicalTrials.gov/show/NCT00002321 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002243 |
A Study to Evaluate the Safety and Effectiveness of a New Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), (+)-Calanolide A, in HIV-Positive Patients Who Have Never Received Anti-HIV Treatment |
https://ClinicalTrials.gov/show/NCT00002243 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002171 |
A Study of Viracept in HIV-Positive Women |
https://ClinicalTrials.gov/show/NCT00002171 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002098 |
Phase I/II Study of the Tolerance and Efficacy of Combined Use of Didanosine (2’,3’-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients |
https://ClinicalTrials.gov/show/NCT00002098 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002033 |
A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease |
https://ClinicalTrials.gov/show/NCT00002033 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00001997 |
Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals |
https://ClinicalTrials.gov/show/NCT00001997 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00000772 |
A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals |
https://ClinicalTrials.gov/show/NCT00000772 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000735 |
A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC |
https://ClinicalTrials.gov/show/NCT00000735 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000667 |
A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells |
https://ClinicalTrials.gov/show/NCT00000667 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000664 |
Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic Individuals |
https://ClinicalTrials.gov/show/NCT00000664 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000648 |
A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals |
https://ClinicalTrials.gov/show/NCT00000648 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000633 |
A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals |
https://ClinicalTrials.gov/show/NCT00000633 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00001474 |
Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients |
https://ClinicalTrials.gov/show/NCT00001474 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |